Product Name | Levoketoconazole - API |
Product Code | DA-L198-a |
Chemical name | Levoketoconazole |
Synonyms | (-)-Ketoconazole; (-)-(2S,4R)-Ketoconazole; Recorlev; 1-[4-[4-[[(2S,4R)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]ethanone; Piperazine, 1-acetyl-4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-; Piperazine, 1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, (2S-cis)-; |
Impurity | NA |
CAS Number | 142128-57-2 |
Alternate CAS # | NA |
Molecular form | C26H28Cl2N4O4 |
Appearance | NA |
Melting Point | NA |
Mol. Weight | 531.43 |
Storage | 2-8°C Refrigerator |
Solubility | NA |
Stability | NA |
Category | enzyme activators,enzyme inhibitors,metabolites,pharmaceutical standards,intermediates,Fine Chemicals |
Boiling Point | NA |
Applications | (-)-Ketoconazole along with other Ketoconazle stereoisomers can be used in pharmacological activity and biological study for inducing CYP4501A1 in human and mouse hepatoma. (-)-Ketoconazole has adverse effect as impurities contained in antifungal drug ketoconazole are potent activators of human aryl hydrocarbon receptor. |
Dangerous Goods Info | NA |
References | NA |
Extra Notes | NA |
Documents (MSDS) | No Data Available |
Keywords | NA |